Management of myeloma-associated renal dysfunction in the era of novel therapies-Reference-Cited by-同舟云学术

Management of myeloma-associated renal dysfunction in the era of novel therapies

Published:2012-02 Issue:1 Volume:5 Page:51-68
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Gaballa Mahmoud R,Laubach Jacob P,Schlossman Robert L,Redman Katherine,Noonan Kimberly,Mitsiades Constantine S,Ghobrial Irene M,Munshi Nikhil,Anderson Kenneth C,Richardson Paul G

Publisher

Informa UK Limited

Subject

Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1586/ehm.11.72

Reference130 articles.

1. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

2. RENAL INVOLVEMENT IN MULTIPLE MYELOMA: A 10-YEAR STUDY

3. Kidney disease associated with plasma cell dyscrasias

4. Improved survival in multiple myeloma and the impact of novel therapies

5. Plasma Cell Disorders: An Historical Perspective

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal miR‐21‐5p derived from multiple myeloma cells promote renal epithelial–mesenchymal transition through targeting TGF‐β/SMAD7 signalling pathway;Clinical and Experimental Pharmacology and Physiology;2023-06-13

2. Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients;BMC Nephrology;2020-06-15

3. The Emerging Role of Innate Immunity in Chronic Kidney Diseases;International Journal of Molecular Sciences;2020-06-04

4. Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras;Bone Marrow Transplantation;2019-09-26

5. Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Therapies;Update on Multiple Myeloma;2019-02-20